Loading...
Header Logo
Keywords
Last Name
Institution

Dr Suman Rijal

Title[no position]
Institution[no institution name]
Address[no address]
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Polman K, Becker SL, Alirol E, Bhatta NK, Bhattarai NR, Bottieau E, Bratschi MW, Burza S, Coulibaly JT, Doumbia MN, Horié NS, Jacobs J, Khanal B, Landouré A, Mahendradhata Y, Meheus F, Mertens P, Meyanti F, Murhandarwati EH, N'Goran EK, Peeling RW, Ravinetto R, Rijal S, Sacko M, Saye R, Schneeberger PH, Schurmans C, Silué KD, Thobari JA, Traoré MS, van Lieshout L, van Loen H, Verdonck K, von Müller L, Yansouni CP, Yao JA, Yao PK, Yap P, Boelaert M, Chappuis F, Utzinger J. Erratum to: Diagnosis of neglected tropical diseases among patients with persistent digestive disorders (diarrhoea and/or abdominal pain =14 days): a multi-country, prospective, non-experimental case-control study. BMC Infect Dis. 2015 Nov 04; 15:499. PMID: 26537896.
      View in: PubMed
    2. Hendrickx S, Leemans A, Mondelaers A, Rijal S, Khanal B, Dujardin JC, Delputte P, Cos P, Maes L. Comparative Fitness of a Parent Leishmania donovani Clinical Isolate and Its Experimentally Derived Paromomycin-Resistant Strain. PLoS One. 2015; 10(10):e0140139. PMID: 26469696.
      View in: PubMed
    3. Polman K, Becker SL, Alirol E, Bhatta NK, Bhattarai NR, Bottieau E, Bratschi MW, Burza S, Coulibaly JT, Doumbia MN, Horié NS, Jacobs J, Khanal B, Landouré A, Mahendradhata Y, Meheus F, Mertens P, Meyanti F, Murhandarwati EH, N'Goran EK, Peeling RW, Ravinetto R, Rijal S, Sacko M, Saye R, Schneeberger PH, Schurmans C, Silué KD, Thobari JA, Traoré MS, van Lieshout L, van Loen H, Verdonck K, von Müller L, Yansouni CP, Yao JA, Yao PK, Yap P, Boelaert M, Chappuis F, Utzinger J. Diagnosis of neglected tropical diseases among patients with persistent digestive disorders (diarrhoea and/or abdominal pain =14 days): Pierrea multi-country, prospective, non-experimental case-control study. BMC Infect Dis. 2015 Aug 18; 15:338. PMID: 26282537.
      View in: PubMed
    4. Ostyn B, Uranw S, Bhattarai NR, Das ML, Rai K, Tersago K, Pokhrel Y, Durnez L, Marasini B, Van der Auwera G, Dujardin JC, Coosemans M, Argaw D, Boelaert M, Rijal S. Transmission of Leishmania donovani in the Hills of Eastern Nepal, an Outbreak Investigation in Okhaldhunga and Bhojpur Districts. PLoS Negl Trop Dis. 2015; 9(8):e0003966. PMID: 26252494.
      View in: PubMed
    5. Pradhan B, Hadengue A, Chappuis F, Chaudhary S, Baral D, Gache P, Karki P, Rijal S. Alcoholic liver disease in Nepal: identifying homemade alcohol as a culprit. Clin Exp Gastroenterol. 2015; 8:183-9. PMID: 26203269.
      View in: PubMed
    6. Ghosh P, Hasnain MG, Ghosh D, Hossain F, Baker J, Boelaert M, Rijal S, Mondal D. A comparative evaluation of the performance of commercially available rapid immunochromatographic tests for the diagnosis of visceral leishmaniasis in Bangladesh. Parasit Vectors. 2015 Jun 16; 8:331. PMID: 26077956.
      View in: PubMed
    7. Banjara MR, Kroeger A, Huda MM, Kumar V, Gurung CK, Das ML, Rijal S, Das P, Mondal D. Feasibility of a combined camp approach for vector control together with active case detection of visceral leishmaniasis, post kala-azar dermal leishmaniasis, tuberculosis, leprosy and malaria in Bangladesh, India and Nepal: an exploratory study. Trans R Soc Trop Med Hyg. 2015 Jun; 109(6):408-15. PMID: 25918216.
      View in: PubMed
    8. Picado A, Ostyn B, Rijal S, Sundar S, Singh SP, Chappuis F, Das ML, Khanal B, Gidwani K, Hasker E, Dujardin JC, Vanlerberghe V, Menten J, Coosemans M, Boelaert M. Long-lasting insecticidal nets to prevent visceral leishmaniasis in the Indian subcontinent; methodological lessons learned from a cluster randomised controlled trial. PLoS Negl Trop Dis. 2015 Apr; 9(4):e0003597. PMID: 25856238.
      View in: PubMed
    9. Boettcher JP, Siwakoti Y, Milojkovic A, Siddiqui NA, Gurung CK, Rijal S, Das P, Kroeger A, Banjara MR. Visceral leishmaniasis diagnosis and reporting delays as an obstacle to timely response actions in Nepal and India. BMC Infect Dis. 2015 Feb 06; 15:43. PMID: 25656298.
      View in: PubMed
    10. Bhattarai S, K C S, Pradhan PM, Lama S, Rijal S. Hepatitis B vaccination status and needle-stick and sharps-related Injuries among medical school students in Nepal: a cross-sectional study. BMC Res Notes. 2014 Nov 03; 7:774. PMID: 25366873.
      View in: PubMed
    11. Boelaert M, Verdonck K, Menten J, Sunyoto T, van Griensven J, Chappuis F, Rijal S. Rapid tests for the diagnosis of visceral leishmaniasis in patients with suspected disease. Cochrane Database Syst Rev. 2014 Jun 20; (6):CD009135. PMID: 24947503.
      View in: PubMed
    12. Ostyn B, Hasker E, Dorlo TP, Rijal S, Sundar S, Dujardin JC, Boelaert M. Failure of miltefosine treatment for visceral leishmaniasis in children and men in South-East Asia. PLoS One. 2014; 9(6):e100220. PMID: 24941345.
      View in: PubMed
    13. Van Horn KS, Zhu X, Pandharkar T, Yang S, Vesely B, Vanaerschot M, Dujardin JC, Rijal S, Kyle DE, Wang MZ, Werbovetz KA, Manetsch R. Antileishmanial activity of a series of N²,N4-disubstituted quinazoline-2,4-diamines. J Med Chem. 2014 Jun 26; 57(12):5141-56. PMID: 24874647.
      View in: PubMed
    14. Stauch A, Duerr HP, Picado A, Ostyn B, Sundar S, Rijal S, Boelaert M, Dujardin JC, Eichner M. Model-based investigations of different vector-related intervention strategies to eliminate visceral leishmaniasis on the Indian subcontinent. PLoS Negl Trop Dis. 2014 Apr; 8(4):e2810. PMID: 24762676.
      View in: PubMed
    15. Picado A, Ostyn B, Singh SP, Uranw S, Hasker E, Rijal S, Sundar S, Boelaert M, Chappuis F. Risk factors for visceral leishmaniasis and asymptomatic Leishmania donovani infection in India and Nepal. PLoS One. 2014; 9(1):e87641. PMID: 24498159.
      View in: PubMed
    16. Hasker E, Malaviya P, Gidwani K, Picado A, Ostyn B, Kansal S, Singh RP, Singh OP, Chourasia A, Kumar Singh A, Shankar R, Wilson ME, Khanal B, Rijal S, Boelaert M, Sundar S. Strong association between serological status and probability of progression to clinical visceral leishmaniasis in prospective cohort studies in India and Nepal. PLoS Negl Trop Dis. 2014; 8(1):e2657. PMID: 24466361.
      View in: PubMed
    17. Dorlo TP, Rijal S, Ostyn B, de Vries PJ, Singh R, Bhattarai N, Uranw S, Dujardin JC, Boelaert M, Beijnen JH, Huitema AD. Failure of miltefosine in visceral leishmaniasis is associated with low drug exposure. J Infect Dis. 2014 Jul 01; 210(1):146-53. PMID: 24443541.
      View in: PubMed
    18. Rai K, Cuypers B, Bhattarai NR, Uranw S, Berg M, Ostyn B, Dujardin JC, Rijal S, Vanaerschot M. Relapse after treatment with miltefosine for visceral leishmaniasis is associated with increased infectivity of the infecting Leishmania donovani strain. mBio. 2013 Oct 08; 4(5):e00611-13. PMID: 24105765.
      View in: PubMed
    19. Kumar D, Khanal B, Tiwary P, Mudavath SL, Tiwary NK, Singh R, Koirala K, Boelaert M, Rijal S, Sundar S. Comparative evaluation of blood and serum samples in rapid immunochromatographic tests for visceral leishmaniasis. J Clin Microbiol. 2013 Dec; 51(12):3955-9. PMID: 24048530.
      View in: PubMed
    20. Berg M, Vanaerschot M, Jankevics A, Cuypers B, Maes I, Mukherjee S, Khanal B, Rijal S, Roy S, Opperdoes F, Breitling R, Dujardin JC. Metabolic adaptations of Leishmania donovani in relation to differentiation, drug resistance, and drug pressure. Mol Microbiol. 2013 Oct; 90(2):428-42. PMID: 24020363.
      View in: PubMed
    21. Dujardin JC, Bhattarai NR, Rai K, Vanaerschot M, Uranw S, Ostyn BA, Boelaert M, Rijal S. Reply to Das. Clin Infect Dis. 2013 Nov; 57(9):1365-6. PMID: 23943823.
      View in: PubMed
    22. Dorlo TP, Ostyn BA, Beijnen JH, Boelaert M, Dujardin JC, Rijal S. Reply to Arya and Agarwal. Clin Infect Dis. 2013 Sep; 57(6):917-8. PMID: 23759350.
      View in: PubMed
    23. Ostyn B, Malaviya P, Hasker E, Uranw S, Singh RP, Rijal S, Sundar S, Dujardin JC, Boelaert M. Retrospective Quarterly Cohort Monitoring for patients with Visceral Leishmaniasis in the Indian subcontinent: outcomes of a pilot project. Trop Med Int Health. 2013 Jun; 18(6):725-33. PMID: 23464638.
      View in: PubMed
    24. Uranw S, Meheus F, Baltussen R, Rijal S, Boelaert M. The household costs of visceral leishmaniasis care in south-eastern Nepal. PLoS Negl Trop Dis. 2013; 7(2):e2062. PMID: 23469298.
      View in: PubMed
    25. Rijal S, Ostyn B, Uranw S, Rai K, Bhattarai NR, Dorlo TP, Beijnen JH, Vanaerschot M, Decuypere S, Dhakal SS, Das ML, Karki P, Singh R, Boelaert M, Dujardin JC. Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance. Clin Infect Dis. 2013 Jun; 56(11):1530-8. PMID: 23425958.
      View in: PubMed
    26. Becker SL, Vogt J, Knopp S, Panning M, Warhurst DC, Polman K, Marti H, von Müller L, Yansouni CP, Jacobs J, Bottieau E, Sacko M, Rijal S, Meyanti F, Miles MA, Boelaert M, Lutumba P, van Lieshout L, N'Goran EK, Chappuis F, Utzinger J. Persistent digestive disorders in the tropics: causative infectious pathogens and reference diagnostic tests. BMC Infect Dis. 2013 Jan 24; 13:37. PMID: 23347408.
      View in: PubMed
    27. Uranw S, Hasker E, Roy L, Meheus F, Das ML, Bhattarai NR, Rijal S, Boelaert M. An outbreak investigation of visceral leishmaniasis among residents of Dharan town, eastern Nepal, evidence for urban transmission of Leishmania donovani. BMC Infect Dis. 2013 Jan 18; 13:21. PMID: 23327548.
      View in: PubMed
    28. Devleesschauwer B, Aryal A, Tharmalingam J, Joshi DD, Rijal S, Speybroeck N, Gabriël S, Victor B, Dorny P. Complexities in using sentinel pigs to study Taenia solium transmission dynamics under field conditions. Vet Parasitol. 2013 Mar 31; 193(1-3):172-8. PMID: 23298565.
      View in: PubMed
    29. Uranw S, Ostyn B, Dorlo TP, Hasker E, Dujardin B, Dujardin JC, Rijal S, Boelaert M. Adherence to miltefosine treatment for visceral leishmaniasis under routine conditions in Nepal. Trop Med Int Health. 2013 Feb; 18(2):179-87. PMID: 23199340.
      View in: PubMed
    30. Huda MM, Hirve S, Siddiqui NA, Malaviya P, Banjara MR, Das P, Kansal S, Gurung CK, Naznin E, Rijal S, Arana B, Kroeger A, Mondal D. Active case detection in national visceral leishmaniasis elimination programs in Bangladesh, India, and Nepal: feasibility, performance and costs. BMC Public Health. 2012 Nov 20; 12:1001. PMID: 23164318.
      View in: PubMed
    31. Pradhan B, Chappuis F, Baral D, Karki P, Rijal S, Hadengue A, Gache P. The alcohol use disorders identification test (AUDIT): validation of a Nepali version for the detection of alcohol use disorders and hazardous drinking in medical settings. Subst Abuse Treat Prev Policy. 2012 Oct 05; 7:42. PMID: 23039711.
      View in: PubMed
    32. Cunningham J, Hasker E, Das P, El Safi S, Goto H, Mondal D, Mbuchi M, Mukhtar M, Rabello A, Rijal S, Sundar S, Wasunna M, Adams E, Menten J, Peeling R, Boelaert M. A global comparative evaluation of commercial immunochromatographic rapid diagnostic tests for visceral leishmaniasis. Clin Infect Dis. 2012 Nov 15; 55(10):1312-9. PMID: 22942208.
      View in: PubMed
    33. Picado A, Rijal S, Sundar S, Boelaert M. Visceral leishmaniasis treatment in the Indian subcontinent: how to reach the most vulnerable. Expert Rev Anti Infect Ther. 2012 Aug; 10(8):839-41. PMID: 23030320.
      View in: PubMed
    34. Vanaerschot M, Decuypere S, Downing T, Imamura H, Stark O, De Doncker S, Roy S, Ostyn B, Maes L, Khanal B, Boelaert M, Schönian G, Berriman M, Chappuis F, Dujardin JC, Sundar S, Rijal S. Genetic markers for SSG resistance in Leishmania donovani and SSG treatment failure in visceral leishmaniasis patients of the Indian subcontinent. J Infect Dis. 2012 Sep 01; 206(5):752-5. PMID: 22753945.
      View in: PubMed
    35. Meheus F, Rijal S, Lutumba P, Hendrickx D, Boelaert M. NTD control and health system strengthening. Lancet. 2012 Jun 09; 379(9832):2149-50. PMID: 22682461.
      View in: PubMed
    36. Devleesschauwer B, Aryal A, Joshi DD, Rijal S, Sherchand JB, Praet N, Speybroeck N, Duchateau L, Vercruysse J, Dorny P. Epidemiology of Taenia solium in Nepal: is it influenced by the social characteristics of the population and the presence of Taenia asiatica? Trop Med Int Health. 2012 Aug; 17(8):1019-22. PMID: 22643112.
      View in: PubMed
    37. Hendrickx S, Inocêncio da Luz RA, Bhandari V, Kuypers K, Shaw CD, Lonchamp J, Salotra P, Carter K, Sundar S, Rijal S, Dujardin JC, Cos P, Maes L. Experimental induction of paromomycin resistance in antimony-resistant strains of L. donovani: outcome dependent on in vitro selection protocol. PLoS Negl Trop Dis. 2012; 6(5):e1664. PMID: 22666513.
      View in: PubMed
    38. Banjara MR, Hirve S, Siddiqui NA, Kumar N, Kansal S, Huda MM, Das P, Rijal S, Gurung CK, Malaviya P, Arana B, Kroeger A, Mondal D. Visceral leishmaniasis clinical management in endemic districts of India, Nepal, and bangladesh. J Trop Med. 2012; 2012:126093. PMID: 22649459.
      View in: PubMed
    39. Das M, Roy L, Picado A, Kroeger A, Rijal S, Boelaert M. Deltamethrin and permethrin residue on long-lasting insecticidal nets after 18 months of use in a visceral leishmaniasis-endemic area in Nepal. Trans R Soc Trop Med Hyg. 2012 Apr; 106(4):230-4. PMID: 22381627.
      View in: PubMed
    40. Decuypere S, Vanaerschot M, Brunker K, Imamura H, Müller S, Khanal B, Rijal S, Dujardin JC, Coombs GH. Molecular mechanisms of drug resistance in natural Leishmania populations vary with genetic background. PLoS Negl Trop Dis. 2012; 6(2):e1514. PMID: 22389733.
      View in: PubMed
    41. Uranw S, Ostyn B, Rijal A, Devkota S, Khanal B, Menten J, Boelaert M, Rijal S. Post-kala-azar dermal leishmaniasis in Nepal: a retrospective cohort study (2000-2010). PLoS Negl Trop Dis. 2011 Dec; 5(12):e1433. PMID: 22206030.
      View in: PubMed
    42. Picado A, Singh SP, Vanlerberghe V, Uranw S, Ostyn B, Kaur H, Das ML, Sundar S, Rijal S, Tungu P, Boelaert M, Rowland M. Residual activity and integrity of PermaNet® 2.0 after 24 months of household use in a community randomised trial of long lasting insecticidal nets against visceral leishmaniasis in India and Nepal. Trans R Soc Trop Med Hyg. 2012 Mar; 106(3):150-9. PMID: 22137191.
      View in: PubMed
    43. Stauch A, Sarkar RR, Picado A, Ostyn B, Sundar S, Rijal S, Boelaert M, Dujardin JC, Duerr HP. Visceral leishmaniasis in the Indian subcontinent: modelling epidemiology and control. PLoS Negl Trop Dis. 2011 Nov; 5(11):e1405. PMID: 22140589.
      View in: PubMed
    44. Downing T, Stark O, Vanaerschot M, Imamura H, Sanders M, Decuypere S, de Doncker S, Maes I, Rijal S, Sundar S, Dujardin JC, Berriman M, Schönian G. Genome-wide SNP and microsatellite variation illuminate population-level epidemiology in the Leishmania donovani species complex. Infect Genet Evol. 2012 Jan; 12(1):149-59. PMID: 22119748.
      View in: PubMed
    45. Downing T, Imamura H, Decuypere S, Clark TG, Coombs GH, Cotton JA, Hilley JD, de Doncker S, Maes I, Mottram JC, Quail MA, Rijal S, Sanders M, Schönian G, Stark O, Sundar S, Vanaerschot M, Hertz-Fowler C, Dujardin JC, Berriman M. Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance. Genome Res. 2011 Dec; 21(12):2143-56. PMID: 22038251.
      View in: PubMed
    46. Ostyn B, Gidwani K, Khanal B, Picado A, Chappuis F, Singh SP, Rijal S, Sundar S, Boelaert M. Incidence of symptomatic and asymptomatic Leishmania donovani infections in high-endemic foci in India and Nepal: a prospective study. PLoS Negl Trop Dis. 2011 Oct; 5(10):e1284. PMID: 21991397.
      View in: PubMed
    47. Gidwani K, Picado A, Rijal S, Singh SP, Roy L, Volfova V, Andersen EW, Uranw S, Ostyn B, Sudarshan M, Chakravarty J, Volf P, Sundar S, Boelaert M, Rogers ME. Serological markers of sand fly exposure to evaluate insecticidal nets against visceral leishmaniasis in India and Nepal: a cluster-randomized trial. PLoS Negl Trop Dis. 2011 Sep; 5(9):e1296. PMID: 21931871.
      View in: PubMed
    48. Vanaerschot M, De Doncker S, Rijal S, Maes L, Dujardin JC, Decuypere S. Antimonial resistance in Leishmania donovani is associated with increased in vivo parasite burden. PLoS One. 2011; 6(8):e23120. PMID: 21829701.
      View in: PubMed
    49. Matlashewski G, Arana B, Kroeger A, Battacharya S, Sundar S, Das P, Sinha PK, Rijal S, Mondal D, Zilberstein D, Alvar J. Visceral leishmaniasis: elimination with existing interventions. Lancet Infect Dis. 2011 Apr; 11(4):322-5. PMID: 21453873.
      View in: PubMed
    50. Harhay MO, Olliaro PL, Vaillant M, Chappuis F, Lima MA, Ritmeijer K, Costa CH, Costa DL, Rijal S, Sundar S, Balasegaram M. Who is a typical patient with visceral leishmaniasis? Characterizing the demographic and nutritional profile of patients in Brazil, East Africa, and South Asia. Am J Trop Med Hyg. 2011 Apr; 84(4):543-50. PMID: 21460007.
      View in: PubMed
    51. Dhakal SS, Sharma SK, Bhatta N, Bhattarai S, Karki S, Shrestha S, Rijal S, Karkil P. Clinical features and histological patterns of lupus nephritis in Eastern Nepal. Saudi J Kidney Dis Transpl. 2011 Mar; 22(2):377-80. PMID: 21422651.
      View in: PubMed
    52. Singh SP, Hirve S, Huda MM, Banjara MR, Kumar N, Mondal D, Sundar S, Das P, Gurung CK, Rijal S, Thakur CP, Varghese B, Kroeger A. Options for active case detection of visceral leishmaniasis in endemic districts of India, Nepal and Bangladesh, comparing yield, feasibility and costs. PLoS Negl Trop Dis. 2011 Feb 08; 5(2):e960. PMID: 21347452.
      View in: PubMed
    53. Picado A, Singh SP, Rijal S, Sundar S, Ostyn B, Chappuis F, Uranw S, Gidwani K, Khanal B, Rai M, Paudel IS, Das ML, Kumar R, Srivastava P, Dujardin JC, Vanlerberghe V, Andersen EW, Davies CR, Boelaert M. Longlasting insecticidal nets for prevention of Leishmania donovani infection in India and Nepal: paired cluster randomised trial. BMJ. 2010 Dec 29; 341:c6760. PMID: 21190965.
      View in: PubMed
    54. t'Kindt R, Scheltema RA, Jankevics A, Brunker K, Rijal S, Dujardin JC, Breitling R, Watson DG, Coombs GH, Decuypere S. Metabolomics to unveil and understand phenotypic diversity between pathogen populations. PLoS Negl Trop Dis. 2010 Nov 30; 4(11):e904. PMID: 21152055.
      View in: PubMed
    55. Khanal B, Rijal S, Ostyn B, Picado A, Gidwani K, Menten J, Jacquet D, Lejon V, Chappuis F, Boelaert M. Serological markers for leishmania donovani infection in Nepal: Agreement between direct agglutination test and rK39 ELISA. Trop Med Int Health. 2010 Nov; 15(11):1390-4. PMID: 21998875.
      View in: PubMed
    56. Dinesh DS, Das ML, Picado A, Roy L, Rijal S, Singh SP, Das P, Boelaert M, Coosemans M. Insecticide susceptibility of Phlebotomus argentipes in visceral leishmaniasis endemic districts in India and Nepal. PLoS Negl Trop Dis. 2010 Oct 26; 4(10):e859. PMID: 21049013.
      View in: PubMed
    57. Meheus F, Balasegaram M, Olliaro P, Sundar S, Rijal S, Faiz MA, Boelaert M. Cost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent. PLoS Negl Trop Dis. 2010 Sep 07; 4(9). PMID: 20838649.
      View in: PubMed
    58. Burniston I, Roy L, Picado A, Das M, Rijal S, Rogers M, Coosemans M, Boelaert M, Davies C, Cameron M. Development of an enzyme-linked immunosorbent assay to identify host-feeding preferences of Phlebotomus species (Diptera: Psychodidae) in endemic foci of visceral leishmaniasis in Nepal. J Med Entomol. 2010 Sep; 47(5):902-6. PMID: 20939388.
      View in: PubMed
    59. Hirve S, Singh SP, Kumar N, Banjara MR, Das P, Sundar S, Rijal S, Joshi A, Kroeger A, Varghese B, Thakur CP, Huda MM, Mondal D. Effectiveness and feasibility of active and passive case detection in the visceral leishmaniasis elimination initiative in India, Bangladesh, and Nepal. Am J Trop Med Hyg. 2010 Sep; 83(3):507-11. PMID: 20810811.
      View in: PubMed
    60. Vanaerschot M, Maes I, Ouakad M, Adaui V, Maes L, De Doncker S, Rijal S, Chappuis F, Dujardin JC, Decuypere S. Linking in vitro and in vivo survival of clinical Leishmania donovani strains. PLoS One. 2010 Aug 17; 5(8):e12211. PMID: 20808916.
      View in: PubMed
    61. Khanal B, Picado A, Bhattarai NR, Van Der Auwera G, Das ML, Ostyn B, Davies CR, Boelaert M, Dujardin JC, Rijal S. Spatial analysis of Leishmania donovani exposure in humans and domestic animals in a recent kala azar focus in Nepal. Parasitology. 2010 Sep; 137(11):1597-603. PMID: 20459877.
      View in: PubMed
    62. Rijal S, Uranw S, Chappuis F, Picado A, Khanal B, Paudel IS, Andersen EW, Meheus F, Ostyn B, Das ML, Davies C, Boelaert M. Epidemiology of Leishmania donovani infection in high-transmission foci in Nepal. Trop Med Int Health. 2010 Jul; 15 Suppl 2:21-8. PMID: 20487421.
      View in: PubMed
    63. Clements MF, Gidwani K, Kumar R, Hostomska J, Dinesh DS, Kumar V, Das P, Müller I, Hamilton G, Volfova V, Boelaert M, Das M, Rijal S, Picado A, Volf P, Sundar S, Davies CR, Rogers ME. Measurement of recent exposure to Phlebotomus argentipes, the vector of Indian visceral Leishmaniasis, by using human antibody responses to sand fly saliva. Am J Trop Med Hyg. 2010 May; 82(5):801-7. PMID: 20439958.
      View in: PubMed
    64. Picado A, Das ML, Kumar V, Dinesh DS, Rijal S, Singh SP, Das P, Coosemans M, Boelaert M, Davies C. Phlebotomus argentipes seasonal patterns in India and Nepal. J Med Entomol. 2010 Mar; 47(2):283-6. PMID: 20380311.
      View in: PubMed
    65. Bhattarai NR, Van der Auwera G, Rijal S, Picado A, Speybroeck N, Khanal B, De Doncker S, Das ML, Ostyn B, Davies C, Coosemans M, Berkvens D, Boelaert M, Dujardin JC. Domestic animals and epidemiology of visceral leishmaniasis, Nepal. Emerg Infect Dis. 2010 Feb; 16(2):231-7. PMID: 20113552.
      View in: PubMed
    66. Picado A, Das ML, Kumar V, Kesari S, Dinesh DS, Roy L, Rijal S, Das P, Rowland M, Sundar S, Coosemans M, Boelaert M, Davies CR. Effect of village-wide use of long-lasting insecticidal nets on visceral Leishmaniasis vectors in India and Nepal: a cluster randomized trial. PLoS Negl Trop Dis. 2010 Jan 26; 4(1):e587. PMID: 20126269.
      View in: PubMed
    67. Das ML, Roy L, Rijal S, Paudel IS, Picado A, Kroeger A, Petzold M, Davies C, Boelaert M. Comparative study of kala-azar vector control measures in eastern Nepal. Acta Trop. 2010 Feb; 113(2):162-6. PMID: 19879851.
      View in: PubMed
    68. Rijal S, Bhandari S, Koirala S, Singh R, Khanal B, Loutan L, Dujardin JC, Boelaert M, Chappuis F. Clinical risk factors for therapeutic failure in kala-azar patients treated with pentavalent antimonials in Nepal. Trans R Soc Trop Med Hyg. 2010 Mar; 104(3):225-9. PMID: 19726065.
      View in: PubMed
    69. Rijal A, Rijal S, Bhandari S. Leprosy coinfection with kala-azar. Int J Dermatol. 2009 Jul; 48(7):740-2. PMID: 19570081.
      View in: PubMed
    70. Bhattarai NR, Das ML, Rijal S, van der Auwera G, Picado A, Khanal B, Roy L, Speybroeck N, Berkvens D, Davies CR, Coosemans M, Boelaert M, Dujardin JC. Natural infection of Phlebotomus argentipes with Leishmania and other trypanosomatids in a visceral leishmaniasis endemic region of Nepal. Trans R Soc Trop Med Hyg. 2009 Nov; 103(11):1087-92. PMID: 19345387.
      View in: PubMed
    71. Bhattarai NR, Van der Auwera G, Khanal B, De Doncker S, Rijal S, Das ML, Uranw S, Ostyn B, Praet N, Speybroeck N, Picado A, Davies C, Boelaert M, Dujardin JC. PCR and direct agglutination as Leishmania infection markers among healthy Nepalese subjects living in areas endemic for Kala-Azar. Trop Med Int Health. 2009 Apr; 14(4):404-11. PMID: 19228350.
      View in: PubMed
    72. Das M, Banjara M, Chowdhury R, Kumar V, Rijal S, Joshi A, Akhter S, Das P, Kroeger A. Visceral leishmaniasis on the Indian sub-continent: a multi-centre study of the costs of three interventions for the control of the sandfly vector, Phlebotomus argentipes. Ann Trop Med Parasitol. 2008 Dec; 102(8):729-41. PMID: 19000390.
      View in: PubMed
    73. Alam MZ, Kuhls K, Schweynoch C, Sundar S, Rijal S, Shamsuzzaman AK, Raju BV, Salotra P, Dujardin JC, Schönian G. Multilocus microsatellite typing (MLMT) reveals genetic homogeneity of Leishmania donovani strains in the Indian subcontinent. Infect Genet Evol. 2009 Jan; 9(1):24-31. PMID: 18957333.
      View in: PubMed
    74. Deborggraeve S, Boelaert M, Rijal S, De Doncker S, Dujardin JC, Herdewijn P, Büscher P. Diagnostic accuracy of a new Leishmania PCR for clinical visceral leishmaniasis in Nepal and its role in diagnosis of disease. Trop Med Int Health. 2008 Nov; 13(11):1378-83. PMID: 18803611.
      View in: PubMed
    75. Ostyn B, Vanlerberghe V, Picado A, Dinesh DS, Sundar S, Chappuis F, Rijal S, Dujardin JC, Coosemans M, Boelaert M, Davies C. Vector control by insecticide-treated nets in the fight against visceral leishmaniasis in the Indian subcontinent, what is the evidence? Trop Med Int Health. 2008 Aug; 13(8):1073-85. PMID: 18564350.
      View in: PubMed
    76. Shafer TJ, Rijal SO, Gross GW. Complete inhibition of spontaneous activity in neuronal networks in vitro by deltamethrin and permethrin. Neurotoxicology. 2008 Mar; 29(2):203-12. PMID: 18304643.
      View in: PubMed
    77. Sundar S, Mondal D, Rijal S, Bhattacharya S, Ghalib H, Kroeger A, Boelaert M, Desjeux P, Richter-Airijoki H, Harms G. Implementation research to support the initiative on the elimination of kala azar from Bangladesh, India and Nepal--the challenges for diagnosis and treatment. Trop Med Int Health. 2008 Jan; 13(1):2-5. PMID: 18290995.
      View in: PubMed
    78. Das ML, Singh SP, Vanlerberghe V, Rijal S, Rai M, Karki P, Sundar S, Boelaert M. Population preference of net texture prior to bed net trial in Kala-Azar-endemic areas. PLoS Negl Trop Dis. 2007 Dec 12; 1(3):e100. PMID: 18160976.
      View in: PubMed
    79. Chappuis F, Sundar S, Hailu A, Ghalib H, Rijal S, Peeling RW, Alvar J, Boelaert M. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol. 2007 Nov; 5(11):873-82. PMID: 17938629.
      View in: PubMed
    80. Boelaert M, El-Safi S, Hailu A, Mukhtar M, Rijal S, Sundar S, Wasunna M, Aseffa A, Mbui J, Menten J, Desjeux P, Peeling RW. Diagnostic tests for kala-azar: a multi-centre study of the freeze-dried DAT, rK39 strip test and KAtex in East Africa and the Indian subcontinent. Trans R Soc Trop Med Hyg. 2008 Jan; 102(1):32-40. PMID: 17942129.
      View in: PubMed
    81. Khambu B, Mehta KD, Rijal S, Lamsal M, Majhi S, Baral N. Serum nitrite level and adenosine deaminase activity is altered in visceral leishmaniasis. Nepal Med Coll J. 2007 Mar; 9(1):40-3. PMID: 17593677.
      View in: PubMed
    82. Rijal S, Yardley V, Chappuis F, Decuypere S, Khanal B, Singh R, Boelaert M, De Doncker S, Croft S, Dujardin JC. Antimonial treatment of visceral leishmaniasis: are current in vitro susceptibility assays adequate for prognosis of in vivo therapy outcome? Microbes Infect. 2007 Apr; 9(4):529-35. PMID: 17350306.
      View in: PubMed
    83. Jacquet D, Boelaert M, Seaman J, Rijal S, Sundar S, Menten J, Magnus E. Comparative evaluation of freeze-dried and liquid antigens in the direct agglutination test for serodiagnosis of visceral leishmaniasis (ITMA-DAT/VL). Trop Med Int Health. 2006 Dec; 11(12):1777-84. PMID: 17176341.
      View in: PubMed
    84. Schenkel K, Rijal S, Koirala S, Koirala S, Vanlerberghe V, Van der Stuyft P, Gramiccia M, Boelaert M. Visceral leishmaniasis in southeastern Nepal: a cross-sectional survey on Leishmania donovani infection and its risk factors. Trop Med Int Health. 2006 Dec; 11(12):1792-9. PMID: 17176343.
      View in: PubMed
    85. Sinha AK, Rijal S, Karki P, Majhi S. Incidence of megaloblastic anaemia and its correction in leishmaniasis--a prospective study at BPKIHS hospital, Nepal. Indian J Pathol Microbiol. 2006 Oct; 49(4):528-31. PMID: 17183843.
      View in: PubMed
    86. Laurent T, Rijal S, Yardley V, Croft S, De Doncker S, Decuypere S, Khanal B, Singh R, Schönian G, Kuhls K, Chappuis F, Dujardin JC. Epidemiological dynamics of antimonial resistance in Leishmania donovani: genotyping reveals a polyclonal population structure among naturally-resistant clinical isolates from Nepal. Infect Genet Evol. 2007 Mar; 7(2):206-12. PMID: 17010679.
      View in: PubMed
    87. Chappuis F, Rijal S, Soto A, Menten J, Boelaert M. A meta-analysis of the diagnostic performance of the direct agglutination test and rK39 dipstick for visceral leishmaniasis. BMJ. 2006 Oct 07; 333(7571):723. PMID: 16882683.
      View in: PubMed
    88. Rijal S, Koirala S, Van der Stuyft P, Boelaert M. The economic burden of visceral leishmaniasis for households in Nepal. Trans R Soc Trop Med Hyg. 2006 Sep; 100(9):838-41. PMID: 16406035.
      View in: PubMed
    89. Chappuis F, Rijal S, Jha UK, Desjeux P, Karki BM, Koirala S, Loutan L, Boelaert M. Field validity, reproducibility and feasibility of diagnostic tests for visceral leishmaniasis in rural Nepal. Trop Med Int Health. 2006 Jan; 11(1):31-40. PMID: 16398753.
      View in: PubMed
    90. Decuypere S, Rijal S, Yardley V, De Doncker S, Laurent T, Khanal B, Chappuis F, Dujardin JC. Gene expression analysis of the mechanism of natural Sb(V) resistance in Leishmania donovani isolates from Nepal. Antimicrob Agents Chemother. 2005 Nov; 49(11):4616-21. PMID: 16251303.
      View in: PubMed
    91. Yardley V, Croft SL, De Doncker S, Dujardin JC, Koirala S, Rijal S, Miranda C, Llanos-Cuentas A, Chappuis F. The sensitivity of clinical isolates of Leishmania from Peru and Nepal to miltefosine. Am J Trop Med Hyg. 2005 Aug; 73(2):272-5. PMID: 16103588.
      View in: PubMed
    92. Quispe-Tintaya KW, Laurent T, Decuypere S, Hide M, Bañuls AL, De Doncker S, Rijal S, Cañavate C, Campino L, Dujardin JC. Fluorogenic assay for molecular typing of the Leishmania donovani complex: taxonomic and clinical applications. J Infect Dis. 2005 Aug 15; 192(4):685-92. PMID: 16028139.
      View in: PubMed
    93. Rijal A, Agrawal S, Agarwalla A, Agrawal A, Rijal S. Post-kala-azar dermal leishmaniasis with visceral leishmaniasis: a rare presentation. Int J Dermatol. 2005 Jun; 44(6):494-6. PMID: 15941439.
      View in: PubMed
    94. De Doncker S, Hutse V, Abdellati S, Rijal S, Singh Karki BM, Decuypere S, Jacquet D, Le Ray D, Boelaert M, Koirala S, Dujardin JC. A new PCR-ELISA for diagnosis of visceral leishmaniasis in blood of HIV-negative subjects. Trans R Soc Trop Med Hyg. 2005 Jan; 99(1):25-31. PMID: 15550258.
      View in: PubMed
    95. Rijal S, Boelaert M, Regmi S, Karki BM, Jacquet D, Singh R, Chance ML, Chappuis F, Hommel M, Desjeux P, Van der Stuyft P, Le Ray D, Koirala S. Evaluation of a urinary antigen-based latex agglutination test in the diagnosis of kala-azar in eastern Nepal. Trop Med Int Health. 2004 Jun; 9(6):724-9. PMID: 15189464.
      View in: PubMed
    96. Quispe Tintaya KW, Ying X, Dedet JP, Rijal S, De Bolle X, Dujardin JC. Antigen genes for molecular epidemiology of leishmaniasis: polymorphism of cysteine proteinase B and surface metalloprotease glycoprotein 63 in the Leishmania donovani complex. J Infect Dis. 2004 Mar 15; 189(6):1035-43. PMID: 14999607.
      View in: PubMed
    97. Boelaert M, Rijal S, Regmi S, Singh R, Karki B, Jacquet D, Chappuis F, Campino L, Desjeux P, Le Ray D, Koirala S, Van der Stuyft P. A comparative study of the effectiveness of diagnostic tests for visceral leishmaniasis. Am J Trop Med Hyg. 2004 Jan; 70(1):72-7. PMID: 14971701.
      View in: PubMed
    98. Sah SP, Rijal S, Bhadani PP, Rani S, Koirala S. Visceral leishmaniasis in two cases of leukemia. Southeast Asian J Trop Med Public Health. 2002 Mar; 33(1):25-7. PMID: 12118454.
      View in: PubMed
    Rijal's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description